Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jason J Bergsbaken"'
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1499-1507
Objective Chemotherapy-induced nausea and vomiting (CINV) is a common and potentially debilitating adverse effect of chemotherapy. Refractory CINV can be particularly difficult to control. This report provides details on the implementation and evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09ad4c5b76c180ff509123a7e91d0570
https://doi.org/10.1177/10781552211029702
https://doi.org/10.1177/10781552211029702
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1987-1996
Objective To summarize the proposed mechanisms behind hypertension and QT interval prolongation associated with use of targeted systemic cancer therapies and provide recommendations for monitoring or managing these toxicities. Summary The cardiotoxic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d91665b1da1dd678279b155e6ee63c6e
https://doi.org/10.1177/1078155220958462
https://doi.org/10.1177/1078155220958462
Autor:
Mary S Mably, Dustin A. Deming, Ruth O'Regan, Jason R Jared, Natalie S. Callander, Jason J Bergsbaken, Michael D. Reed, Emily R Hennes
Publikováno v:
American Journal of Health-System Pharmacy. 77:1243-1248
Purpose To design and implement a chemotherapy stewardship process to optimize the location of chemotherapy administration in an effort to decrease the number of inappropriate inpatient anticancer regimen administrations and decrease institutional co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdd043aaed1034bf45ec7a1d0e7d070e
https://doi.org/10.1093/ajhp/zxaa157
https://doi.org/10.1093/ajhp/zxaa157
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:718-729
To summarize similarities and differences in efficacy, safety, and cost of available PARP-inhibitors and offers pearls to distinguish subtle nuances between each agent to help guide therapy.Currently, four PARP-inhibitors (olaparib, rucaparib, nirapa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d75cb85dc02d7d8a81023f433a8f8469
https://doi.org/10.1177/1078155219895066
https://doi.org/10.1177/1078155219895066
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:345-350
Purpose To improve patient safety and reduce drug waste through implementation of automated parenteral chemotherapy dose-banding within an electronic health record. Methods Parenteral chemotherapy dose-rounding practices were transitioned from a manu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73b861b7bbfa4d0a99bfd3a08c5c1d6c
https://doi.org/10.1177/1078155219846958
https://doi.org/10.1177/1078155219846958
Publikováno v:
Journal of Oncology Pharmacy Practice. 25:954-960
Introduction The development of immune checkpoint inhibitors has revolutionized cancer treatment and is now a part of the treatment paradigm for several malignancies. Although immune checkpoint inhibitors are generally well tolerated, treatment is as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c2d5bd6b52ae36f21902a93be144774
https://doi.org/10.1177/1078155218817937
https://doi.org/10.1177/1078155218817937
Autor:
Keng Hee Peh, Daniel J Przybylski, Michael J Fallon, Jason J Bergsbaken, Paul R Hutson, Menggang Yu, Dustin A Deming, Mark E Burkard
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522210912
Purpose Molecular tumor boards provide precision treatment recommendations based on cancer genomic profile. However, practical barriers limit their benefits. We studied the clinical utility of the precision medicine molecular tumor board (PMMTB) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dce1cb6f189aaa9db6a7712cd4b1a5c
https://doi.org/10.1177/10781552221091282
https://doi.org/10.1177/10781552221091282
Autor:
Jacqueline L. Olin, Adam Peele, Marc Earl, Jeffrey S. Reichard, Danielle L Roman, Ali McBride, Jason J Bergsbaken
Publikováno v:
American Journal of Health-System Pharmacy. 75:1304-1311
The roles and responsibilities of the pharmacy technician in ambulatory oncology practice have evolved considerably over the past several decades. Historically, technician roles consisted mainly of compounding and technical activities, but technician
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15dec4299373bf437200681034114176
https://doi.org/10.2146/ajhp180270
https://doi.org/10.2146/ajhp180270
Autor:
Jason J Bergsbaken, Kim Noonan, Hope S. Rugo, Eun-Jeong Kim, David S. Ettinger, Dorothy A. Shead, Dwight D. Kloth, Sally Y. Barbour, Laura Boehnke Michaud, Charles L. Loprinzi, Philip J. Bierman, Ruth Lagman, Georgiana Ellis, John P. Timoney, Susan G. Urba, Michael Berger, Debra Brandt, Bridget Scullion, Victoria Maurer, Dawn E. Dolan, Miranda Hughes, Jonathan Aston, Barbara Todaro, Lee S. Schwartzberg, Cynthia X. Ma, Lisle Nabell, Eric Roeland, Steve Kirkegaard, Dean Lim
Publikováno v:
Journal of the National Comprehensive Cancer Network. 15:883-893
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed0c9d291e4de2b9dea3cb127f1b06f
https://doi.org/10.6004/jnccn.2017.0117
https://doi.org/10.6004/jnccn.2017.0117
Autor:
Aaron Bohler, Jessica Fischer, Mary J. Mulkerin, Jason J Bergsbaken, Mary S Mably, Daniel Mulkerin
Publikováno v:
Journal of Oncology Practice. 12:e912-e923
Purpose: Use of oral chemotherapy is expanding and offers advantages while posing unique safety challenges. ASCO and the Oncology Nursing Society jointly published safety standards for administering chemotherapy that offer a framework for improving o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f78168d9d797ca8039b3acdb2011a8
https://doi.org/10.1200/jop.2016.013748
https://doi.org/10.1200/jop.2016.013748